10 Followers on Owler

Medivir AB

Medivir is a research-based pharmaceutical company that focuses on developing medicines for cancer. Read more

Christine Lind's photo - CEO of Medivir AB

CEO

Christine Lind

CEO Approval Rating

68/100

Founded:

1988

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

MEDIVIR AB TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Moberg Pharma is seen as one of Medivir AB's top competitors. Moberg Pharma was founded in Bromma, Other} in 2006. Moberg Pharma is in the Health Care Services industry. Compared to Medivir AB, Moberg Pharma generates $51.3M more revenue.

Trimb is Medivir AB's #2 competitor. Trimb was founded in 2012, and its headquarters is in Stockholm, Stockholms län. Trimb is in the Pharmaceuticals field. Trimb has 90 more employees than Medivir AB.

Navamedic is Medivir AB's #3 rival. Navamedic is headquartered in Lysaker, Akershus, and was founded in 2002. Navamedic operates in the Pharmaceuticals industry. Navamedic generates ∞% the revenue of Medivir AB.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Orifarm Group A/S a competitor of Medivir AB?

Medivir AB Acquisitions

No recent acquisitions found related to Medivir AB

Medivir AB Funding History

No recent funding data found related to Medivir AB

Medivir AB Investments

No recent investments found related to Medivir AB

Medivir AB News

April 27, 2018WardsAuto

Medivir AB - Interim Report January - March 2018

HUDDINGE, Sweden, 27 April, 2018 /PRNewswire/ -- Significant events during the quarter The holders of... See more »
April 14, 2018BioPortfolio

Medivir AB Mergers Acquisitions MA Partnerships Alliances and Investment Report Report Updated 18022018 Prices from USD $350

Medivir AB Mergers Acquisitions MA Partnerships Alliances and Investment ReportSummaryMarketline's Me... See more »
April 13, 2018WardsAuto

New Preclinical Data on MIV-818 Will be Presented at the AACR Annual Meeting in April

STOCKHOLM, Sweden, April 13, 2018 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today informs t... See more »
April 4, 2018WardsAuto

Medivir's Annual Report for 2017 is Published

STOCKHOLM, April 4, 2018 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the... See more »
March 30, 2018BioPortfolio

Medivir AB MVIR B Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13032018 Prices from USD $250

SummaryMedivir AB Medivir is a biopharmaceutical company which focuses on research and develops new d... See more »
March 28, 2018Benzinga

Conversion of all Class A Shares in Medivir to Class B Shares - Prospectus Published

Conversion of all Class A Shares in Medivir to Class B Shares - Prospectus PublishedPR NewswireSTOCKH... See more »
March 15, 2018WardsAuto

Medivir - The Nomination Committee´s Proposal for New Board of Directors to the Annual General Meeting 2018

STOCKHOLM, March 15, 2018 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces the Nom... See more »

Medivir AB Press Releases

January 26, 2018ForImmediateRelease

Resolutions at the Extraordinary General Meeting in Medivir on 26 January 2018

Travel & Tourism Industry release: HUDDINGE, Sweden, Jan. 26, 2018 /PRNewswire/ - The Extraordinary G... See more »
January 8, 2018ForImmediateRelease

Successful Completion of Pre-clinical Safety Studies With MIV-818, Enabling Start of Phase I Clinical Studies in 2018

Travel & Tourism Industry release: STOCKHOLM, Jan. 8, 2018 /PRNewswire/ - Medivir AB (Nasdaq Stockhol... See more »
January 1, 2018streetinsider

Medivir's Series A Shares to be Converted Into Series B Shares

Medivir AB (publ) ("Medivir" or the "Company") (Nasdaq Stockholm: MVIR) today announces that the hold... See more »
November 3, 2017PR Newswire

Medivir Appoints Erik Björk as Chief Financial Officer

HUDDINGE, Sweden, Nov. 3, 2017 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announces today th... See more »
October 13, 2017PR Newswire

Remetinostat Phase II Data Demonstrate Efficacy on Skin Lesions, Reduction of Itching and High Tolerability in Patients With Early-stage MF-type CTCL

STOCKHOLM, Oct. 13, 2017 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that pha... See more »
September 26, 2017PR Newswire

Medivir Announces Positive Topline Results from Phase IIa Osteoarthritis Study, Showing Disease-modifying Benefit of MIV-711 on Joint Structure

STOCKHOLM, Sept. 25, 2017 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces positiv... See more »
September 13, 2017PR Newswire

Data Monitoring Committee Gives 'Go Ahead' in the MIV-711 Osteoarthritis Extension Study

STOCKHOLM, Sept. 14, 2017 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that th... See more »

Social Media

Medivir AB Headquarters

Blasieholmsgatan 2

Stockholm, Stockholms län111 48

08-54-68-3100

Driving Directions »

Trending Companies

Medivir AB Summary

ABOUT

Overview

Medivir is a research-based pharmaceutical company that focuses on developing medicines for cancer. Medivir AB was founded in 1988. Medivir AB's headquarters is located in Stockholm, Stockholms län, SE 111 48. Medivir AB's CEO, Christine Lind, curren...

CEO

Medivir AB's CEO, Christine Lind, currently has an approval rating of 68%. Medivir AB's primary competitors are Moberg Pharma, Trimb & Navamedic.

Website

medivir.se

Frequently Asked Questions about Medivir AB

  1. When was Medivir AB founded?

    Medivir AB was founded in 1988
  2. Who is Medivir AB's CEO?

    Medivir AB's CEO is Christine Lind
  3. How much revenue does Medivir AB generate?

    Medivir AB generates $ < 1M in revenue
  4. How much funding does Medivir AB have?

    Medivir AB has historically raised $0 in funding
  1. Where is Medivir AB's headquarters?

    Medivir AB's headquarters is in Stockholm Stockholms län, SE
  2. How many employees does Medivir AB have?

    Medivir AB has 0 employees
  3. Who are Medivir AB's competitors?

    Medivir AB's top competitors are Moberg Pharma, Trimb, Navamedic